$1.96
+0.14 (+7.69%)
Analyst Consensus
Sell
13
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+986.7% upside
Low Target
$14.71
Average Target
$21.30
High Target
$34.17
Current Price
$1.96
Current
$1.96
$1.96
Target
$21.30
$21.30
$14.71
$21.30 avg
$34.17
Scenario Analysis
Bear Case
$14.71
650.5%
Low target
Base Case
$21.30
+986.7%
Avg target
Bull Case
$34.17
+1,643.4%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$28.67
-93.2% from high
52-Week Low
$10.08
+-80.6% from low
Target vs 52W High
$21.30
-25.7% vs high
Next Earnings Report
Mar 3, 2026 · After Market Close
15d
until earnings
EPS Est: $-0.41
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 37 | 68% | $257.58 | +15.3% |
| AMGN | Hold | 41 | 54% | $190.87 | -50.3% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +137.8% |
| VRTX | Strong Buy | 39 | 77% | $438.34 | -8.3% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -90.2% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -68.8% |
| INSM | Strong Buy | 27 | 93% | $143.40 | -4.3% |
| BIIB | Hold | 42 | 48% | $91.45 | -54.5% |